Medical
-
A study by University of Washington researchers published in the September 2011 issue of Anesthesia & Analgesia, the official journal of the International Anesthesia Research Society, demonstrates improved delivery of morphine and fentanyl in rats… Read more . . .
-
Verona Pharma has successfully completed a Phase 2 study of the duration of bronchodilator action by its lead drug RPL554 in patients with mild asthma, according to the company. RPL554 is a novel long-acting phosphodiesterase… Read more . . .
-
The FDA has approved a pre-market approval (PMA) application from Intersect ENT for its Propel mometasone furoate drug delivery implant for the treatment of chronic sinusitis. The dissolvable device is inserted in the sinus cavity… Read more . . .
-
NexBio, which was recently raided by the US Federal Bureau of Investigation (FBI), has announced results from a Phase 2 clinical trial of its Fludase inhaled antiviral for the treatment of influenza. According to the… Read more . . .
-
After a meeting with the FDA, MannKind Corporation has announced that the company and the agency have confirmed protocols for new efficacy and safety studies of Afrezza inhaled insulin. The original studies of Afrezza were… Read more . . .
-
The UK Medicines and Healthcare products Regulatory Agency (MHRA) is warning consumers against using a “fake tan nasal spray” marketed as Ubertan. According to the agency, the product comes in two versions, one of which… Read more . . .
-
According to the US Health and Human Service Department’s Agency for Healthcare Research and Quality (AHRQ), the average annual cost of prescription drugs to treat a child with asthma in the US rose from $349… Read more . . .
-
Michigan-based biopharmaceutical company NanoBio has announced plans to advance its intranasal influenza vaccine into human trials after publishing results from a successful ferret study of the vaccine. The data gained from the ferret study appears… Read more . . .
-
MedImmune has announced its submission of a supplemental Biologics License Application to the FDA for a version of its FluMist intranasal influenza vaccine that includes 4 strains of influenza virus as opposed to the usual… Read more . . .
-
A study by Harvard researchers published in the New England Journal of Medicine found that patients reported similar relief of symptoms from use of a placebo inhaler compared to use of an albuterol inhaler. Although… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland